The Bottom Line Pharmacy Podcast: Sykes & Company, P.A.

Welcome to the Bottom Line Pharmacy Podcast! On this show, we bring you valuable insights from pharmacists, key vendors and other innovators to bring you pharmacy CPA advice and fuel your bottom line. Subscribe wherever you listen to podcasts for the latest in independent pharmacy!

The Bottom Line Pharmacy Podcast: Sykes & Company, P.A. is a business podcast hosted by Unknown Host, with 154 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts The Bottom Line Pharmacy Podcast: Sykes & Company, P.A., a business show with 154 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  The Bottom Line Pharmacy Podcast: Sykes & Company, P.A.

  The Bottom Line Catch Up | Ep. 4 | Peptides, Nexus Issues & Trade Show Takeaways

  Sep 11, 202644 min

  Send us Fan Mail Welcome to another episode of the Bottom Line Catch Up! This week our team is talking all about Peptides, Nexus Issues, and Trade Show Trends. In this episode, we break down: - Where things stand with the FDA Bulks List and state-by-state variation - Nexus issues for pharmacies shipping and operating across state lines - MFP (Maximum Fair Price) accounting - Takeaways from Cencora, RBC, and other summer shows - Plus: fantasy football team names, upcoming conferences (APC, NCPA), and a few tangents you'd expect from the crew Stay connected with us: Facebook Twitter LinkedIn Scotty Sykes – CPA, CFP LinkedIn Scotty Sykes – CPA, CFP Twitter Bonnie Bond – CPA LinkedIn Bonnie Bond – CPA Twitter More resources on this topic: Podcast - The Bottom Line Catch Up | Ep. 3 | R&D Tax Credit, Trump Accounts, Taylor Swift's Wedding Podcast – Peptides, Policy, and PBMs: 2026 Quarter 3 Pharmacy Update Podcast – Infusion Pharmacy Ownership in 2026: The Legal Side of Infusion Pharmacy

  ListenShow Notes
• 

  The Bottom Line Pharmacy Podcast: Sykes & Company, P.A.

  Distributor Injunctive Relief: What Every Pharmacy Needs to Know with Brown & Fortunato

  Sep 10, 202637 min

  Send us Fan Mail Schedule an Rx Assessment Your pharmacy's controlled substance monitoring might not be enough and your distributor may be watching too. On this episode of the Bottom Line Pharmacy Podcast, we sit down with Michael Alexander of Brown & Fortunato to break down: What distributor injunctive relief is How the "Big Three" distributors are now required to flag suspicious controlled substance orders What to do if you get a letter or call from your distributor about your ordering activity Whether proactive outreach to your distributor helps or hurts you When to bring in legal counsel And more! Stay connected with Michael Alexander and Brown & Fortunato: Michael Alexander LinkedIn Brown & Fortunato Website Brown & Fortunato LinkedIn Brown & Fortunato Facebook Stay connected with us: Facebook Twitter LinkedIn Scotty Sykes – CPA, CFP LinkedIn Scotty Sykes – CPA, CFP Twitter Bonnie Bond – CPA LinkedIn Bonnie Bond – CPA Twitter More resources on this topic: Podcast - Peptides, Policy, and PBMs: 2026 Quarter 3 Pharmacy Update Podcast – Driving Independent Pharmacy Profitability in 2026 with Nicolette Mathey, PharmD, CEO of Atrium24 Podcast – The Bottom Line Catch Up | Ep. 3 | R&D Tax Credit, Trump Accounts, Taylor Swift's Wedding

  ListenShow Notes
• 

  The Bottom Line Pharmacy Podcast: Sykes & Company, P.A.

  Infusion Pharmacy Ownership in 2026: The Legal Side of Infusion Pharmacy with Boesen & Snow Law

  Sep 3, 202617 min

  Send us Fan Mail Schedule an Rx Assessment Your infusion pharmacy is scaling fast, but is your legal foundation keeping up? On this episode of the Bottom Line Pharmacy Podcast, we sit down with Chris Pucillo and Patrick Carpenter of Boesen & Snow Law to break down: Why home infusion pharmacies are consolidating in 2026, and what's driving it The state-by-state licensing patchwork that trips up new infusion clinics What regulatory and financial due diligence actually looks like when buying or selling an infusion pharmacy Where anti-kickback risk hides in doctor detailing and cash-pay pricing And more! Stay connected with Patrick Carpenter, Chris Pucillo and Boesen & Snow Law: Patrick Carpenter LinkedIn Chris Pucillo LinkedIn Boesen & Snow Website Boesen & Snow LinkedIn Boesen & Snow Facebook Stay connected with us: Facebook Twitter LinkedIn Scotty Sykes – CPA, CFP LinkedIn Scotty Sykes – CPA, CFP Twitter Bonnie Bond – CPA LinkedIn Bonnie Bond – CPA Twitter More resources on this topic: Podcast - Peptides, Policy, and PBMs: 2026 Quarter 3 Pharmacy Update Podcast – Driving Independent Pharmacy Profitability in 2026 with Nicolette Mathey, PharmD, CEO of Atrium24 Podcast – The Bottom Line Catch Up | Ep. 3 | R&D Tax Credit, Trump Accounts, Taylor Swift's Wedding

  ListenShow Notes
• 

  The Bottom Line Pharmacy Podcast: Sykes & Company, P.A.

  Peptides, Policy, and PBMs: 2026 Quarter 3 Pharmacy Update with Annie West and Dae Lee

  Aug 20, 202630 min

  Send us Fan Mail Schedule an Rx Assessment A LOT has happened recently in the Peptide market, but what exactly is new with peptides, the FDA, and the future of independent pharmacy? On this episode of the Bottom Line Pharmacy Podcast, we're joined for our typical quarterly pharmacy update with ⁨@atrium24⁩ . Annie West, Clinical Pharmacy Director and Dae Lee, PBM & Pharmacy Practice Group Board Co-Chair at Buchanan, Ingersoll & Rooney, P.C. to break down: The two-day PCAC meeting and the committee's recommendation What happens next in the FDA rulemaking process The dangerous peptide gray market The latest on PBM policy And more! Stay connected with Atrium24 and Dae Lee: Dae Lee LinkedIn Atrium24 Website Atrium24 LinkedIn Atrium24 Instagram Atrium24 Facebook Stay connected with us: Facebook Twitter LinkedIn Scotty Sykes – CPA, CFP LinkedIn Scotty Sykes – CPA, CFP Twitter Bonnie Bond – CPA LinkedIn Bonnie Bond – CPA Twitter More resources on this topic: Podcast - Inside a Pharmacy AI Bot: Automating Independent Pharmacy Podcast – Driving Independent Pharmacy Profitability in 2026 with Nicolette Mathey, PharmD, CEO of Atrium24 Podcast – 2026 Quarter 2 Pharmacy Update Podcast – R&D Tax Credit, Trump Accounts, Taylor Swift's Wedding

  ListenShow Notes
• 

  The Bottom Line Pharmacy Podcast: Sykes & Company, P.A.

  The Bottom Line Catch Up | Ep. 3 | R&D Tax Credit, Trump Accounts, Taylor Swift's Wedding

  Aug 14, 202616 min

  Send us Fan Mail Schedule an Rx Assessment Welcome to another episode of the Bottom Line Catch Up and the team is buzzing about Taylor Swift's wedding and World Cup fever! In this episode, we break down: R&D tax credit documentation requirements for 2026 Trump Accounts going live for kids Trade show season And more! Stay connected with us: Facebook Twitter LinkedIn Scotty Sykes – CPA, CFP LinkedIn Scotty Sykes – CPA, CFP Twitter Bonnie Bond – CPA LinkedIn Bonnie Bond – CPA Twitter More resources on this topic: Podcast - The Bottom Line Catch Up | Ep. 1 | Tax Season, Transitions, and the Peptide Wave P odcast – Driving Independent Pharmacy Profitability in 2026 with Nicolette Mathey, PharmD, CEO of Atrium24 Podcast – 2026 Quarter 2 Pharmacy Update

  ListenShow Notes

Recent guests on The Bottom Line Pharmacy Podcast: Sykes & Company, P.A.. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.